In this Issue:
Efavirenz and suicidal ideation/suicide
Tenofovir/emtricitabine tenofovir prophylaxis for HSV-2
HIV risk reduction with buprenorphine-naloxone or methadone
25-hydroxyvitamin D deficiency and HIV progression
Dolutegravir for integrase inhibitor-resistant HIV-1
Reversibility of estimated GFR decline after tenofovir
Early vs delayed highly active ART for HIV patients with TB
Dual vs triple therapy for HIV-1
Causes of death in people with HIV from 1999 to 2011
Second-line antiretroviral regimens for HIV
Please login below to download this issue (PDF)